{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:52:13Z","timestamp":1789908733446,"version":"4.0.1"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:00:00Z","timestamp":1495152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ejphar.2017.05.038","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T01:31:01Z","timestamp":1495503061000},"page":"178-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections"],"prefix":"10.1016","volume":"809","author":[{"given":"Simonides I.","family":"van de Wakker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel J.E.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S.","family":"Oosting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejphar.2017.05.038_bib1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s11418-016-1001-5","article-title":"Medicinal significance of naturally occurring cyclotetrapeptides","volume":"70","author":"Abdalla","year":"2016","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.ejphar.2017.05.038_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4161\/viru.25779","article-title":"Endothelial activation and dysfunction in the pathogenesis of influenza A virus infection","volume":"4","author":"Armstrong","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.ejphar.2017.05.038_bib3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/AAC.03947-14","article-title":"Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro","volume":"59","author":"Belardo","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2017.05.038_bib4","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1021\/nn402062f","article-title":"Inhibition of influenza A virus infection in vitro by saliphenylhalamide-loaded porous silicon nanoparticles","volume":"7","author":"Bimbo","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejphar.2017.05.038_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/JVI.01593-15","article-title":"Duck interferon-inducible transmembrane protein 3 mediates restriction of influenza viruses","volume":"90","author":"Blyth","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib6","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/092986708784049658","article-title":"Arbidol: a broad-spectrum antiviral compound that blocks viral fusion","volume":"15","author":"Boriskin","year":"2008","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.ejphar.2017.05.038_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virusres.2006.09.013","article-title":"Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes","volume":"124","author":"Boulo","year":"2007","journal-title":"Virus Res."},{"key":"10.1016\/j.ejphar.2017.05.038_bib8","article-title":"The effect of statins on influenza-like illness morbidity and mortality","author":"Brassard","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ejphar.2017.05.038_bib9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2017.05.038_bib10","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/AAC.04623-14","article-title":"Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit","volume":"59","author":"Byrn","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2017.05.038_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/CCM.0000000000001616","article-title":"Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia","volume":"44","author":"Cao","year":"2016","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2017.05.038_bib12","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1128\/JVI.00361-07","article-title":"Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles","volume":"81","author":"Chen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.antiviral.2013.06.014","article-title":"Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses","volume":"99","author":"Chen","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2017.05.038_bib14","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1021\/jm2013503","article-title":"Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein","volume":"55","author":"Cheng","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2017.05.038_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbrc.2016.06.111","article-title":"A novel p38 mitogen activated protein kinase (MAPK) specific inhibitor suppresses respiratory syncytial virus and influenza A virus replication by inhibiting virus-induced p38 MAPK activation","volume":"477","author":"Choi","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2017.05.038_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.celrep.2012.12.010","article-title":"Influenza A virus utilizes suboptimal splicing to coordinate the timing of infection","volume":"3","author":"Chua","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2017.05.038_bib17","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1073\/pnas.1200987109","article-title":"Influenza A virus entry into cells lacking sialylated N-glycans","volume":"109","author":"De Vries","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2017.05.038_bib18","doi-asserted-by":"crossref","first-page":"e1001329","DOI":"10.1371\/journal.ppat.1001329","article-title":"Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway","volume":"7","author":"De Vries","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejphar.2017.05.038_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.08.002","article-title":"Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo","volume":"92","author":"Droebner","year":"2011","journal-title":"Antivir. Res."},{"issue":"12","key":"10.1016\/j.ejphar.2017.05.038_bib20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S1473-3099(14)70821-7","article-title":"Antiviral combinations for severe influenza","volume":"14","author":"Dunning","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejphar.2017.05.038_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1099\/vir.0.059477-0","article-title":"Entry of influenza A virus: host factors and antiviral targets","volume":"95","author":"Edinger","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib22","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/cmi.12108","article-title":"The NF-\u03baB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance","volume":"15","author":"Ehrhardt","year":"2013","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib23","doi-asserted-by":"crossref","first-page":"e1001099","DOI":"10.1371\/journal.ppat.1001099","article-title":"The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells","volume":"6","author":"Eierhoff","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejphar.2017.05.038_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10921","article-title":"IFITM3 restricts the morbidity and mortality associated with influenza","volume":"484","author":"Everitt","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2017.05.038_bib25","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1017\/S0950268810000105","article-title":"An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998\u20131999 to 2005\u20132006","volume":"138","author":"Fleming","year":"2010","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.ejphar.2017.05.038_bib26","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1378\/chest.06-1997","article-title":"Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins","volume":"131","author":"Frost","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2017.05.038_bib27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2017.05.038_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1743-422X-5-85","article-title":"6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry","volume":"5","author":"Gambaryan","year":"2008","journal-title":"Virol. J."},{"key":"10.1016\/j.ejphar.2017.05.038_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.virol.2004.09.036","article-title":"Interaction of influenza virus proteins with nucleosomes","volume":"332","author":"Garcia-Robles","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.ejphar.2017.05.038_bib30","doi-asserted-by":"crossref","first-page":"15366","DOI":"10.1073\/pnas.1107906108","article-title":"Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers","volume":"108","author":"Gerritz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2017.05.038_bib31","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1128\/AAC.48.12.4855-4863.2004","article-title":"Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells","volume":"48","author":"Govorkova","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2017.05.038_bib32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2015.07.003","article-title":"Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever","volume":"121","author":"Gowen","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2017.05.038_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02568-15","article-title":"Virus and host mechanics support membrane penetration and cell entry","author":"Greber","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.antiviral.2013.03.006","article-title":"Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro","volume":"98","author":"Haasbach","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2017.05.038_bib35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.antiviral.2013.06.008","article-title":"The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus","volume":"99","author":"Haasbach","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2017.05.038_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(14)70717-0","article-title":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b\/3 trial","volume":"14","author":"Haffizulla","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejphar.2017.05.038_bib37","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1038\/ncomms3854","article-title":"Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility","volume":"4","author":"Hai","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2017.05.038_bib38","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3390\/v4071144","article-title":"Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion","volume":"4","author":"Hamilton","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.ejphar.2017.05.038_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5694\/j.1326-5377.2006.tb00705.x","article-title":"The influenza viruses","volume":"185","author":"Hampson","year":"2006","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ejphar.2017.05.038_bib40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1462-5822.2006.00781.x","article-title":"A broad antiviral neutral glycolipid, fattiviracin FV-8, is a membrane fluidity modulator","volume":"9","author":"Harada","year":"2007","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib41","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1074\/jbc.M112.437202","article-title":"Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus","volume":"288","author":"Hendricks","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2017.05.038_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0014-5793(96)00783-1","article-title":"Involvement of annexin V in the entry of influenza viruses and role of phospholipids in infection","volume":"392","author":"Huang","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2017.05.038_bib43","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1128\/JVI.00727-14","article-title":"Histone deacetylase 6 inhibits influenza A virus release by downregulating the trafficking of viral components to the plasma membrane via its substrate, acetylated microtubules","volume":"88","author":"Husain","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib44","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.3390\/v5102424","article-title":"Transport of the influenza virus genome from nucleus to nucleus","volume":"5","author":"Hutchinson","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.ejphar.2017.05.038_bib45","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1128\/AAC.01579-07","article-title":"Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice","volume":"52","author":"Ilyushina","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2017.05.038_bib46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/135965350701200302","article-title":"Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice","volume":"12","author":"Ilyushina","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ejphar.2017.05.038_bib47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/135965350300800301","article-title":"Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza","volume":"8","author":"Ison","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ejphar.2017.05.038_bib48","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0300985813513043","article-title":"Influenza A virus infections in swine: pathogenesis and diagnosis","volume":"51","author":"Janke","year":"2014","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib49","doi-asserted-by":"crossref","first-page":"e1000462","DOI":"10.1371\/journal.ppat.1000462","article-title":"Genetic trans-complementation establishes a new model for influenza virus RNA transcription and replication","volume":"5","author":"Jorba","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejphar.2017.05.038_bib50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1359-6101(00)00026-5","article-title":"Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression","volume":"12","author":"Julkunen","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejphar.2017.05.038_bib51","doi-asserted-by":"crossref","first-page":"e1005062","DOI":"10.1371\/journal.ppat.1005062","article-title":"A novel antiviral target structure involved in the RNA binding, dimerization, and nuclear export functions of the influenza A virus nucleoprotein","volume":"11","author":"Kakisaka","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejphar.2017.05.038_bib52","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1128\/AAC.05529-11","article-title":"Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation","volume":"55","author":"Kim","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2017.05.038_bib53","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4161\/rna.20345","article-title":"Architecture and regulation of negative-strand viral enzymatic machinery","volume":"9","author":"Kranzusch","year":"2012","journal-title":"RNA Biol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib54","doi-asserted-by":"crossref","first-page":"495","DOI":"10.18388\/abp.2014_1870","article-title":"Antivirals--current trends in fighting influenza","volume":"61","author":"Kr\u00f3l","year":"2014","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib55","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/S0006-3495(94)80721-0","article-title":"Kinetics of the low pH-induced conformational changes and fusogenic activity of influenza hemagglutinin","volume":"67","author":"Krumbiegel","year":"1994","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejphar.2017.05.038_bib56","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.antiviral.2012.09.013","article-title":"Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection","volume":"96","author":"Lee","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2017.05.038_bib57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7774\/cevr.2014.3.1.12","article-title":"New vaccines against influenza virus","volume":"3","author":"Lee","year":"2014","journal-title":"Clin. Exp. Vaccin. Res."},{"key":"10.1016\/j.ejphar.2017.05.038_bib58","first-page":"84","article-title":"Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A","volume":"77","author":"Leneva","year":"2005","journal-title":"Ter. Arkh"},{"key":"10.1016\/j.ejphar.2017.05.038_bib59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2008.10.009","article-title":"Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol","volume":"81","author":"Leneva","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2017.05.038_bib60","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejmech.2015.08.016","article-title":"Synthesis and inhibitory effects of novel pyrimido-pyrrolo-quinoxalinedione analogues targeting nucleoproteins of influenza A virus H1N1","volume":"102","author":"Lin","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2017.05.038_bib61","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/aps.2013.121","article-title":"Characteristics of human infection with avian influenza viruses and development of new antiviral agents","volume":"34","author":"Liu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2017.05.038_bib62","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1128\/JVI.01680-06","article-title":"Influenza seasonality: underlying causes and modeling theories","volume":"81","author":"Lofgren","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib63","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1128\/JVI.01705-10","article-title":"N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN","volume":"85","author":"Londrigan","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib64","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1007\/s00018-014-1615-2","article-title":"Antiviral strategies against influenza virus: towards new therapeutic approaches","volume":"71","author":"Loregian","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2017.05.038_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkp161","article-title":"Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy","volume":"64","author":"Ludwig","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejphar.2017.05.038_bib66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jhep.2009.10.015","article-title":"Safety and efficacy of viramidine versus ribavirin in ViSER2: randomized, double-blind study in therapy-naive hepatitis C patients","volume":"52","author":"Marcellin","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib67","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1073\/pnas.0812689106","article-title":"A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection","volume":"106","author":"Marsolais","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2017.05.038_bib68","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/JVI.65.1.232-244.1991","article-title":"Transport of incoming influenza virus nucleocapsids into the nucleus","volume":"65","author":"Martin","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-12-407698-3.00004-1","article-title":"Influenza virus transcription and replication","volume":"87","author":"Mart\u00edn-Benito","year":"2013","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.ejphar.2017.05.038_bib70","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1021\/jm1002183","article-title":"Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy","volume":"53","author":"Matsubara","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2017.05.038_bib71","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1462-5822.2007.00902.x","article-title":"Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity","volume":"9","author":"Mazur","year":"2007","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2016.01.012","article-title":"Meeting report: 4th ISIRV antiviral group conference: novel antiviral therapies for influenza and other respiratory viruses","volume":"129","author":"McKimm-Breschkin","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2017.05.038_bib73","doi-asserted-by":"crossref","first-page":"872370","DOI":"10.1155\/2014\/872370","article-title":"Mechanisms of action and efficacy of statins against influenza","volume":"2014","author":"Mehrbod","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ejphar.2017.05.038_bib74","doi-asserted-by":"crossref","first-page":"e19705","DOI":"10.1371\/journal.pone.0019705","article-title":"Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression","volume":"6","author":"Michaelis","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2017.05.038_bib75","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/17460441.2015.1019859","article-title":"Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza","volume":"10","author":"Monod","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejphar.2017.05.038_bib76","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/infdis\/jis622","article-title":"A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection","volume":"206","author":"Moss","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2017.05.038_bib77","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1476-5381.2011.01346.x","article-title":"The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections","volume":"164","author":"M\u00fcller","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib78","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jpba.2015.03.014","article-title":"Catechin inhibition of influenza neuraminidase and its molecular basis with mass spectrometry","volume":"111","author":"M\u00fcller","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejphar.2017.05.038_bib79","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1128\/JVI.00126-16","article-title":"Influenza A virus dysregulates host histone deacetylase 1 that inhibits viral infection in lung epithelial cells","volume":"90","author":"Nagesh","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib80","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ajpath.2011.03.013","article-title":"Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis","volume":"179","author":"Narasaraju","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5492\/wjccm.v5.i1.89","article-title":"Corticosteroids for severe influenza pneumonia: a critical appraisal","volume":"5","author":"Nedel","year":"2016","journal-title":"World J. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2017.05.038_bib82","first-page":"121","article-title":"Orthomyxovirus replication, transcription, and polyadenylation","volume":"283","author":"Neumann","year":"2004","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib83","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1096\/fj.08-112110","article-title":"Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design","volume":"22","author":"Ng","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2017.05.038_bib84","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.antiviral.2013.04.012","article-title":"The use of sialidase therapy for respiratory viral infections","volume":"98","author":"Nicholls","year":"2013","journal-title":"Antivir. Res."},{"issue":"Pt 5","key":"10.1016\/j.ejphar.2017.05.038_bib85","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1099\/vir.0.038679-0","article-title":"A novel family of peptides with potent activity against influenza A viruses","volume":"93","author":"Nicol","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib86","doi-asserted-by":"crossref","first-page":"8915","DOI":"10.1021\/jm401369y","article-title":"New 7-methylguanine derivatives targeting the influenza polymerase PB2 cap-binding domain","volume":"56","author":"Pautus","year":"2013","journal-title":"J. Med Chem."},{"key":"10.1016\/j.ejphar.2017.05.038_bib87","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1128\/JVI.01774-14","article-title":"Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo","volume":"88","author":"Perwitasari","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib88","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/35060098","article-title":"Influenza virus propagation is impaired by inhibition of the Raf\/MEK\/ERK signalling cascade","volume":"3","author":"Pleschka","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib89","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1002\/j.1460-2075.1989.tb08565.x","article-title":"Identification of four conserved motifs among the RNA-dependent polymerase encoding elements","volume":"8","author":"Poch","year":"1989","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2017.05.038_bib90","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12703\/P6-47","article-title":"Advances in influenza vaccination","volume":"6","author":"Reperant","year":"2014","journal-title":"F1000Prime Rep."},{"key":"10.1016\/j.ejphar.2017.05.038_bib91","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4161\/rna.8.2.14513","article-title":"The influenza virus RNA synthesis machine: advances in its structure and function","volume":"8","author":"Resa-Infante","year":"2011","journal-title":"RNA Biol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib92","first-page":"3","article-title":"Corticosteroids as adjunctive therapy in the treatment of influenza","author":"Rodrigo","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2017.05.038_bib93","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1099\/0022-1317-81-11-2697","article-title":"Entry of influenza viruses into cells is inhibited by a highly specific protein kinase C inhibitor","volume":"81","author":"Root","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib94","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.virol.2010.12.003","article-title":"Influenza virus assembly and budding","volume":"411","author":"Rossman","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.ejphar.2017.05.038_bib95","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3851\/IMP2475","article-title":"Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics","volume":"18","author":"Seo","year":"2013","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ejphar.2017.05.038_bib96","doi-asserted-by":"crossref","first-page":"16515","DOI":"10.1073\/pnas.1113107108","article-title":"E339...R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors","volume":"108","author":"Shen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2017.05.038_bib97","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.apsb.2015.07.006","article-title":"New small-molecule drug design strategies for fighting resistant influenza A","volume":"5","author":"Shen","year":"2015","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.ejphar.2017.05.038_bib98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/infdis\/jiq005","article-title":"Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008\u20132010","volume":"203","author":"Sheu","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2017.05.038_bib99","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fmicb.2014.00653","article-title":"Influenza virus and endothelial cells: a species specific relationship","volume":"5","author":"Short","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2005.06.003","article-title":"In vitro and in vivo influenza virus-inhibitory effects of viramidine","volume":"68","author":"Sidwell","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2017.05.038_bib101","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/JVI.77.1.460-469.2003","article-title":"Role of protein kinase C betaII in influenza virus entry via late endosomes","volume":"77","author":"Sieczkarski","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib102","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1034\/j.1600-0854.2003.00090.x","article-title":"Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses","volume":"4","author":"Sieczkarski","year":"2003","journal-title":"Traffic"},{"issue":"10","key":"10.1016\/j.ejphar.2017.05.038_bib103","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.3390\/v7102883","article-title":"Perspective of Use of Antiviral Peptides against Influenza Virus","volume":"7","author":"Skalickova","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.ejphar.2017.05.038_bib104","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5414\/CP201843","article-title":"Pharmacokinetics of single and multiple oral doses of arbidol in healthy Chinese volunteers","volume":"51","author":"Sun","year":"2013","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2017.05.038_bib105","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00705-013-1922-1","article-title":"In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus","volume":"159","author":"Tarbet","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib106","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cell.2011.08.015","article-title":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection","volume":"146","author":"Teijaro","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2017.05.038_bib107","doi-asserted-by":"crossref","first-page":"e7838","DOI":"10.1371\/journal.pone.0007838","article-title":"Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein","volume":"4","author":"Triana-Baltzer","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2017.05.038_bib108","doi-asserted-by":"crossref","first-page":"e1003297","DOI":"10.1371\/journal.ppat.1003297","article-title":"A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion","volume":"9","author":"Vigant","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejphar.2017.05.038_bib109","doi-asserted-by":"crossref","first-page":"12018","DOI":"10.1073\/pnas.1107024108","article-title":"Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2017.05.038_bib110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00430-010-0182-x","article-title":"Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate","volume":"200","author":"Wiesener","year":"2011","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib111","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1128\/AAC.17.4.642","article-title":"Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice","volume":"17","author":"Wilson","year":"1980","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2017.05.038_bib112","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1073\/pnas.0909587107","article-title":"A broad-spectrum antiviral targeting entry of enveloped viruses","volume":"107","author":"Wolf","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2017.05.038_bib113","doi-asserted-by":"crossref","first-page":"421","DOI":"10.18388\/abp.2014_1859","article-title":"Structural biology of the influenza virus fusion peptide","volume":"61","author":"Worch","year":"2014","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib114","doi-asserted-by":"crossref","first-page":"30931","DOI":"10.1074\/jbc.M403258200","article-title":"NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas\/FasL is crucial for efficient influenza virus propagation","volume":"279","author":"Wurzer","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2017.05.038_bib115","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1183\/09031936.00130507","article-title":"Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice","volume":"33","author":"Xu","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2017.05.038_bib116","doi-asserted-by":"crossref","first-page":"e1002316","DOI":"10.1371\/journal.ppat.1002316","article-title":"Histone deacetylase 8 is required for centrosome cohesion and influenza A virus entry","volume":"7","author":"Yamauchi","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejphar.2017.05.038_bib117","doi-asserted-by":"crossref","first-page":"L270","DOI":"10.1152\/ajplung.00011.2014","article-title":"Suppression of influenza A virus replication in human lung epithelial cells by noncytotoxic concentrations bafilomycin A1","volume":"308","author":"Yeganeh","year":"2015","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib118","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1128\/JVI.06159-11","article-title":"Identification and characterization of three novel nuclear export signals in the influenza A virus nucleoprotein","volume":"86","author":"Yu","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib119","doi-asserted-by":"crossref","first-page":"e835","DOI":"10.1038\/cddis.2013.367","article-title":"Drugs to cure avian influenza infection--multiple ways to prevent cell death","volume":"4","author":"Yuan","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2017.05.038_bib120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.antiviral.2015.09.008","article-title":"Phase 1 clinical trials of DAS181, an inhaled sialidase, in healthy adults","volume":"123","author":"Zenilman","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2017.05.038_bib121","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/viro.2000.0228","article-title":"The cytoplasmic tails of the influenza virus spike glycoproteins are required for normal genome packaging","volume":"269","author":"Zhang","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.ejphar.2017.05.038_bib122","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00705-015-2668-8","article-title":"The c-Jun N-terminal kinase (JNK) is involved in H5N1 influenza A virus RNA and protein synthesis","volume":"161","author":"Zhang","year":"2016","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ejphar.2017.05.038_bib123","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1038\/emi.2014.80","article-title":"Drug susceptibility profile and pathogenicity of H7N9 influenza virus (Anhui1 lineage) with R292K substitution","volume":"3","author":"Zhang","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ejphar.2017.05.038_bib124","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1073\/pnas.0711942105","article-title":"Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A\/H5N1 virus","volume":"105","author":"Zheng","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2017.05.038_bib125","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.febslet.2013.02.048","article-title":"Structure and assembly of the influenza A virus ribonucleoprotein complex","volume":"587","author":"Zheng","year":"2013","journal-title":"FEBS Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917303709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917303709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T13:50:14Z","timestamp":1692798614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299917303709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":125,"alternative-id":["S0014299917303709"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.038","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}